chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on throat, chest, back and legs; This is a spontaneous report from a contactable healthcare professional.  A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular on the left arm on 19Dec2020 07:45 at single dose for COVID-19 immunisation.  Medical history included known allergies: penicillin.  The patient's concomitant medications were not reported.  The patient experienced rash on throat, chest, back and legs on 19Dec2020 11:30. Patient does not receive any treatment. The outcome of the events was recovering.
Patient said he had a very sore right arm for about three days following his two immunizations.  Ten days after administraction, while lifting heavy objects, he experienced a sharp pain in the injection site area.  Since then he periodically experinces sharp pain and numbness, associated with lifting and other work.  As of yet has not sought any medical treatment at the time of reporting (10/15/15).
The pt had a fever, first hot then cold, shaking, she had problems breathing. Her face was red (flushed) then pale and she would not eat. They symptoms lasted 2 days. The pt has had prior reactions.
Flu-like symptoms: high fever, chills, aches, right arm numb, severe headache. Treatment - 10 days Ceclor 250 mg.
A few minutes after administering the vaccine, patient slumped off of bench to floor then vomited a few minutes later.   It appeared that she fainted but did not fully lose consciousness, she caught herself on hands and knees, and did not hit her head.  She confirmed she did not eat before coming to the pharmacy for vaccine. She was monitored for 15-20 minutes after until all symptoms resolved.  Recommended she report fainting history and eat before any future vaccines.
3/11/2021 vaccination  3/12/2021 3 am, I woke up with HA. By 10AM, I was calling hotline because HA started to get worse.  'If gets worse, go to the ER'.  HA persisted for 24 hours. The next day started to subside but still very bad HA. I still considered it bad but not debilitating.
Menstrual period ended July 21, 2021 Vaccine given July 27, 2021 Menstrual period began again Aug 3, 2021, period still present as of Aug 9, 2021 Lower back pains throughout, still intense as of today Aug 9, 2031
Within 1 day of injection, patient noted a red rash over the site (LD) of injection with area of induration under skin.  Rash is described as red papules with no pruritis
Patient reports sausage swelling in hands in March, hard to make fist, for 2 weeks. Resolved. Came back 3 days after first Covid 19 vaccines. Resolved in 2 weeks. After 2nd Covid 19 dose 4/29/2021, 2 days later symptoms came back, hard to straighten fingers, Left middle trigger finger, difficulty closing, stiffness ini PIP joints.   Patient declined cortisone for trigger finger.  Treated with hand exercise, anti-inflammatory diet, turmeric.
Pain and swelling at injection site, cold sweats, shivering, headaches, lethargy.
Patient received FluMist. While in observation, patient became lightheaded then became unconscious and had seizure like activity lasting approx. 10 secs. Patient lowered to ground level with feet elevated. Vital signs taken. 911 called. Patient transported to Emergency Room by EMS. After seizure activity, patient was alert and oriented x 3; reported being evaluated for symptoms by a neurologist.
Blistering vesicular rash, almost cellulitis in nature, in leg with DTAP and IPV.
1 small urticarial lesion with 1/10th dose Novartis brand in pt with hx of egg allergy who tolerates baked goods with egg. He was give BENADRYL. He had no other symptoms. Had tolerated Sanofi Pasteur last year.
This spontaneous report as received from a healthcare worker refers to a patient of unspecified age and gender. No current or historical conditions were reported. On 13-NOV-2014 the patient was vaccinated with the first dose of ROTATEQ (lot # K005394; expiration date: 23-FEB-2016, dosage information was not provided) orally, which was improperly stored. There were no concomitant medications reported. No adverse effect reported. There was no product quality complaint (PQC) involved. The outcome was unknown. This is one of several reports received from the same reporter. Additional information is not expected because the reporter had no further information available.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 26-JUL-2012, the patient was inoculated (by an unspecified person) with ZOSTAVAX at a medical clinic, as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration and lot # were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. During 2016, the patient was treated (by an unspecified healthcare professional) at a medical clinic for a persistent and severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.
This spontaneous report was received from a nurse refers to a 14 year old female patient. On 20-DEC-2012 the patient was vaccinated with GARDASIL (dosing regimen unspecified) dose 3. It was reported that nurse states on 20-DEC-2012 a patient was vaccinated with the third dose of GARDASIL too early. Patient was vaccinated with GARDASIL first dose 22-AUG-2012, second dose 25-OCT-2012 and the third dose of GARDASIL on 20-DEC-2012. Nurse states patient vaccinated at another facility. No adverse effects reported. The outcome of patient was vaccinated with the third dose of GARDASIL too early and no adverse effects reported is unknown. No product complaint involved. This is one of several reports received from the same source. Additional information is not expected.
This spontaneous report as received from a nurse practitioner refers to 2 unspecified patients of unknown age and gender. There were no information about patients' concomitant medications and pertinent medical history reported. On 14-JAN-2016, the patients might have received improperly stored PEDVAXHIB, intramuscularly, lot# reported as L030871, expiry date: 10-JUN-2018 (dose was not reported). No adverse effects were reported. Additional information has been requested.
Generalized red raised rash on trunk now spreading to arms and legs 1 week post smallpox vaccine.
about 1 1/2 to 2 inch bright red rash, with a slightly raised hard core just above the right elbow (area of lymph node), there was about a 100 degree temperature limited to the rash site with normal temperature above and below site and general body temperature being normal. By morning it was fading away and within 24 hours rash was gone with slight lump that gradually faded away over the next 24 hours. There may have been a slight red flushing lower inner surface of the same arm that still seems to be there, but no elevated temperature, tenderness or significant redness compared to the original localized rash. The injection site never reddened but had a slight tenderness for 24-48 hours.
By phone call, pt reported a period of light headedness and dizziness about 18-20 hrs after the vaccine, lasting about 1 hour, self resolved after visit to school nurse office.
Swelling, redness, itching, no problems with breathing, fever of 102F (reported 5/30/15 by daughter).
received dose after expiration time/Administering vaccine after expiration; the vial was exposed to room temperature range 8° to 25°C= 46° to 77°F; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose after expiration time/Administering vaccine after expiration) and PRODUCT STORAGE ERROR (the vial was exposed to room temperature range 8° to 25°C= 46° to 77°F) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose after expiration time/Administering vaccine after expiration) and PRODUCT STORAGE ERROR (the vial was exposed to room temperature range 8° to 25°C= 46° to 77°F). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (received dose after expiration time/Administering vaccine after expiration) and PRODUCT STORAGE ERROR (the vial was exposed to room temperature range 8° to 25°C= 46° to 77°F) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug details were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 18-Oct-2021: Non-significant Follow Up received updated Event verbatim.
22Sep03: He presents with mild swelling, severe erythema and exudate on both tonsils and complaint of fever.  Throat culture taken.  1.2 mil units Bicillin given IM. Rapid Strep test negative. 23Sep03: Increased to moderate swelling of tonsils and throat pain despite Motrin.  Late evening went to ER and given Decadron.  By next morning pain much better. Repeat RST negative. 24Sep03: Mild improvement in tonsilar swelling and erythema.  Exudate still severe. Monospot negative. Start Zithromax. Viral culture sent to center per DOD instructions.  Spoke to DOD Vaccine Center.   26Sep03: Patient symptoms much improved and no fever in 1 1/2 days. Exam with only mild erythema and no exudate. Throat culture negative
Day 1-2 Right arm pain , Chills, Fever  Day 3 - present day   Right axilla swelling size of a ping pong ball ,   Fever, Fatigue
Patient developed fever, muscle aches, cough and fatigue, tested positive for Covid-19 on 1/17/22 and was admitted to hospital on 1/16/2022
DIARRHEA; UNABLE TO WORK; PAIN IN HIPS AND NECKS; WEAK MUSCLES; HURTING IN BOTH SHOULDERS; HEADACHE; FEELING TIRED; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 19-SEP-2021) dose was not reported, administered on 11-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-AUG-2021, the patient experienced pain in hips and necks. On 12-AUG-2021, the patient experienced weak muscles. On 12-AUG-2021, the patient experienced hurting in both shoulders. On 12-AUG-2021, the patient experienced headache. On 12-AUG-2021, the patient experienced feeling tired. On 13-AUG-2021, the patient experienced unable to work. On 13-AUG-2021, the patient experienced diarrhea. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from diarrhea, and had not recovered from headache, pain in hips and necks, feeling tired, weak muscles, hurting in both shoulders, and unable to work. This report was non-serious.
On Wednesday night 12/07/2022 I was so exhausted and the next day I was not feeling quite perfect and my husband had tested positive for COVID-19 plus I had an earache and a tiny bit of a scratchy throat. By Friday morning I had a sore throat, fatigued, achy and my ear hurt at that time I tested positive for COVID-19 with a rapid at home test. I was prescribed PAXLOVID and a eleven day course of prednisone.
some of it leaked onto her arm; some of it leaked onto her arm; inadvertent exposure; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number PG35Z, expiry date 11th March 2023) for prophylaxis.   On 1st October 2021, the patient received the 1st dose of Shingrix. On 1st October 2021, unknown after receiving Shingrix, the patient experienced incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine. On an unknown date, the outcome of the incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine were unknown.  Additional details were provided as follows: The pharmacist reported that during administration of Shingrix to the patient some of the vaccine leaked on patient's arm, which led to incomplete dose administered, exposure via skin contact and inadvertent exposure to vaccine. The reporter consented to follow up.
Information has been received from a nurse practitioner concerning a female patient (age not reported) who on an unspecified date was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). Subsequently, the patient fainted post vaccination. She stated that it "felt like the medicine traveled through my system at time of injection." Subsequently, the patient recovered from the syncope and abnormal feeling. The nurse reported that the patient was not disoriented, was very aware and her blood pressure (actual BP not reported) was within normal limits. The patient was offered a sugar drink (soda) after the event and recovered from the event. The nurse practitioner noted that the patient had eaten before coming in for the vaccination. Additional information has been requested.
Immediately after the injection and for the next 36 hours, I had soreness in my right arm where the injection was.  Around 8:15pm, I started to develop chills. From there, I developed a fever, headache, neck soreness and body aches in my joints (particularly wrists, knees, elbows). I contained the fever with extra strength Tylenol taken according to the box instructions. The fever broke overnight.  I had a 99 degree temperature the next day (3:00 pm) after the vaccine, and experienced fatigue and body aches. Those symptoms largely subsided by the morning of 3/21.   I still (as of the PM on 3/22) have no appetite and a persistent feeling of "fullness" in my stomach.
tummy ache; tired; my arm hurt too; I felt icky all weekend; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 03Jun2021 08:17 (Lot number: EW0183) at the age of 43 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Seasonal allergies" (unspecified if ongoing), notes: Seasonal allergies year; "I have corn allergies" (unspecified if ongoing). There were no concomitant medications. The following information was reported: ABDOMINAL PAIN (non-serious) with onset 03Jun2021, outcome "unknown", described as "tummy ache"; FATIGUE (non-serious) with onset 03Jun2021, outcome "unknown", described as "tired"; PAIN IN EXTREMITY (non-serious) with onset 03Jun2021, outcome "unknown", described as "my arm hurt too"; MALAISE (non-serious) with onset 2021, outcome "unknown", described as "I felt icky all weekend".  Additional information: Prior vaccinations within 4 weeks was none.  No follow-up attempts are possible. No further information is expected.
On 07/09/10 mom calls states child injection site red and swollen, child complains of headache and body aches, no fever.  Advised cool compressors to site and Ibuprofen.  If s/s worsen or do not improve go to ER.
Patient came into room hesitant of needles/shot. Stated that he had an aversion to needles and he felt the same way with the first dose of vaccination. After vaccination, patient waited in waiting room as requested, but then at approximately 6:20 pm became very lightheaded, pale, and diaphoretic. Patient never lost consciousness. Was accompanied by wife who talked him through deep breathing. A fan was placed near patient to assist with cooling down and a bottle of water was also given to patient. Over approximately 20-25 minutes, patient regained color, sweating ceased, and felt overall better. Patient was escorted out by wife with no further incident.
3 days post vax, pt experienced rubella. 6 days post vax pt was seen by a physician.
Immediately after receiving the vaccine, my left arm and left side of my neck and back became very sore and I felt very light headed and dizzy. 7 hours later, the back pain worsened and I started sweating a lot. Soon after my skin all over my body began to tingle as if I had bugs crawling all over my body and it was very uncomfortable. During the night I couldn't sleep because I was sweating so much, the back pain was getting worse and worse, and the tingly skin feeling turned into very intense skin sensitivity and hurt any time my body touched something or rubbed against my clothing. At some points I would be extremely hot and sweating a lot and then some points I was freezing cold and shaking uncontrollably. These signs all lasted 24 hours and slowly started going away after 48 hours. After 48 hours, I felt much better and back to "normal" but couldn't help but notice some strange reactions that I still have today, 3 weeks later... I have had acne which is uncommon for me. I have had period cramps and mood swings but am not on my period. I also have had crazy bloating in my stomach and all over my body... swollen legs, feet, hands, etc. I also have been experiencing brain fog where I loose my train of thought in conversation, I can't remember where I put things, I can't remember if I took my eye contacts out or not, or fed the dog... very strange and uncharacteristic of me to be so aloof and forgetful but to the point where I have zero recollection of doing such activities.
Immediately a bump appeared size of a quarter and in 5 min time it went down to size of a penny. Patient stated she has had this happen before but it wasn't as painful. She described this injection as a burning pressure sensation while inject given.
Patient received flu vaccine, invalid dose due to reaching below 0 degrees during transport. Per CDC and Sanofi medical team was advised to treat as if expired vaccine was given and to repeat dose.
hives; rash; itching; This is a spontaneous report from a contactable consumer reported for herself. This 63-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Left Arm on 19May2021 10:30 (Lot Number: EW0182) at single dose for COVID-19 immunisation.  Medical history included Hypothyroid, allergies. The patient's concomitant medications were not reported. Patient was not pregnant.  The patient experienced hives, rash, itching on unspecified date with outcome of recovering - did not relate to vaccine at the time.  Events resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. AE Treatment: Steroid, diphenhydramine hydrochloride (BENADRYL) and famotidine (PEPCID). Patient did not have COVID prior vaccination, and did not have COVID tested post vaccination.
Pt had a syncopal episode after vaccination with HPV.  Paramedics called and she was assessed by providers at the clinic.  Pt stable and parent took her home.
she received the covid vaccine the pain lessened by about 10 to 20 %; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Shingles" (unspecified if ongoing), notes: She has shingles for 5 years. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "she received the covid vaccine the pain lessened by about 10 to 20 %".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tiny pinhead size red bumps on back, head, abdo, face arms & armpit not puritic w/screaming & breath holding spells
I developed R eye redness, pain and photophobia on 1/21 and was diagnosed with anterior uveitis. I am being treated with prednisolone drops and a dilating eye drop. My symptoms have improved significantly with the eye drops. I do not know if this is at all related to the vaccine - I have a h/o one other episode of anterior uveitis in my L eye in 2004, felt to be HLA-B27 associated - however I figure it is worth reporting just in case.
There was no adverse event, but the vaccine was given to him out of the age indication for the vaccine at the time. The patient is 16 years old, and at the time of vaccine administration, the Janssen Covid-19 vaccine was only indicated for ages 18 years old and up.
Hives, severe itching  and SOB within 10 minutes of injection Benadryl and dexamethasone
Itchy, sunburn-like rash appeared near elastic area of undergarment after dose 1 (not at vaccine site on arm).  It seemed to be improving until after second dose, when it spread farther and began to itch more again.  Benadryl helps some, as do aloe and zinc oxide, but rash has not yet resolved.
Swollen lymph nodes upon palpation to left armpit; visible swelling to left armpit; pain to left armpit; This is a spontaneous report from a contactable nurse (patient).  A 33-year-old female patient received the second dose of BNT162B2 (also reported as Pfizer brand, lot no: EK5730), intramuscular on 06Jan2021 at 06:30 at a single dose on the left arm (as reported, also reported as left deltoid) for COVID-19 immunization.  Medical history included anaphylaxis to "unknown chemical substance" while jogging in Oct2014 that resulted in a 4 hr hospitalization in an emergency department. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 on 16Dec2020 at 8:00 PM intramuscular on the left arm for COVID-19 immunization. The patient reported swollen lymph nodes upon palpation to left armpit with noted visible swelling to left armpit as well as pain to left armpit on 07Jan2021 at 6:30 AM. The symptoms were present 24 hours post vaccination intramuscular to the left deltoid (as reported). The patient did not receive any treatment for the reported adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was unknown.